To the full analysis
Genfit stock: growth
GNFT.PAGenfit reported $72.51M in revenue for fiscal 2025, down 2.3% on the prior year, up 143.5% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
10.4%
per year from 2006 to 2025, per share 2.2%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 143.5% | 62.0% | 10.4% |
| Revenue per share | 131.6% | 51.0% | 2.2% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $11.14M | $363.12K | −$3.05M |
| 2007 | $10.5M | −$3.1M | −$5.93M |
| 2008 | $9.71M | −$4.39M | −$6.24M |
| 2009 | $6.44M | −$8.17M | −$550.17K |
| 2010 | $4.16M | −$10.39M | −$6.19M |
| 2011 | $2.62M | −$10.73M | −$8.01M |
| 2012 | $1.85M | −$6M | −$9.04M |
| 2013 | $2.1M | −$14.02M | −$10.45M |
| 2014 | $1.79M | −$18.87M | −$17.96M |
| 2015 | $583.97K | −$18.99M | −$17.35M |
| 2016 | $314.7K | −$37.31M | −$32.43M |
| 2017 | $130.76K | −$64.94M | −$58.35M |
| 2018 | $76.46K | −$88.12M | −$65.4M |
| 2019 | $34.17M | −$72.19M | −$55.08M |
| 2020 | $847.7K | −$112.16M | −$107.79M |
| 2021 | $88.72M | $74.53M | $110.12M |
| 2022 | $22.38M | −$26.28M | −$80.49M |
| 2023 | $31.65M | −$32.02M | −$64.18M |
| 2024 | $74.24M | $1.67M | $15.76M |
| 2025 | $72.51M | −$95.26M | −$29.6M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 2 May 2025)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.